Search

everythinglearnresearchcommunity

for

Search:↓

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Treatment during development affects hormone balance and sexual behavior in male rats.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.